0001628280-21-001279.txt : 20210202 0001628280-21-001279.hdr.sgml : 20210202 20210202151823 ACCESSION NUMBER: 0001628280-21-001279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210129 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hayden Michael R CENTRAL INDEX KEY: 0001352908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 21580986 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z 7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_161229708841560.xml FORM 4 X0306 4 2021-01-29 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001352908 Hayden Michael R #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Shares 2021-01-29 4 M 0 50000 5.44 A 50000 D Common Shares 2021-01-29 4 M 0 30000 6.06 A 80000 D Common Shares 2021-01-29 4 M 0 15000 6.42 A 95000 D Stock Option (right to buy) 5.44 2021-01-29 4 M 0 50000 0 D 2028-02-22 Common Stock 50000.0 0 D Stock Option (right to buy) 6.06 2021-01-29 4 M 0 30000 0 D 2029-01-29 Common Stock 30000.0 0 D Stock Option (right to buy) 6.42 2021-01-29 4 M 0 15000 0 D 2029-07-03 Common Stock 15000.0 0 D Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. /s/ Michael Hayden, Ph.D., M.D. 2021-02-01